ROCHE HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 265.60 CHF | +0.99% |
|
-3.84% | +8.63% |
| Sep. 13 | FDA Approves Roche Treatment of Multiple Sclerosis Using Halozyme Delivery System | MT |
| Sep. 13 | Roche Gets FDA Approval for Multiple-Sclerosis Treatment | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | +0.99% | -3.84% | +8.63% | +4.30% | -1.26% | 248B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Comparison Chart